NCT06210373: Assessment of Efficacy and Safety of the Use of Two Eye Gel Products Containing 5% Dexpanthenol in Patients With Moderate to Severe Dry Eye Syndrome |
|
|
| Recruiting | N/A | 124 | Europe | Myrialen Gel, Dexpanthenol 5%, Recugel | Fidia Farmaceutici s.p.a. | Dry Eye Disease | 11/24 | 12/24 | | |